These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1353595)

  • 1. Bone minerals and levothyroxine.
    Egsmose C; Hegedüs L; Lund B; Hansen JE
    Lancet; 1992 Aug; 340(8816):436. PubMed ID: 1353595
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone minerals and levothyroxine.
    Walker JD; Mariash CN; Oppenheimer JH
    Lancet; 1992 Aug; 340(8816):436-7. PubMed ID: 1353596
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone minerals and levothyroxine.
    Wenzel KW
    Lancet; 1992 Aug; 340(8816):435-6. PubMed ID: 1353594
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bone mineral density in patients on long-term therapy with levothyroxine].
    Korsić M; Cvijetić S; Dekanić-Ozegović D; Bolanća S; Kozić B
    Lijec Vjesn; 1998 May; 120(5):103-5. PubMed ID: 9748785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density in premenopausal women receiving long-term physiological doses of levothyroxine.
    Kung AW; Pun KK
    JAMA; 1991 May 22-29; 265(20):2688-91. PubMed ID: 2023349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring L-thyroxine therapy: lessons from the effects of L-thyroxine on bone density.
    Ross DS
    Am J Med; 1991 Jul; 91(1):1-4. PubMed ID: 1858817
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effects of levothyroxine replacement therapy on bone and mineral metabolism in patients with hypothyroidism].
    Chai R; Ye Z; Zhan Z; Liu W; Yu M; Liu Y
    Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):18-21. PubMed ID: 11798620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Reverter JL; Holgado S; Alonso N; Salinas I; Granada ML; Sanmartí A
    Endocr Relat Cancer; 2005 Dec; 12(4):973-81. PubMed ID: 16322336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroxine replacement therapy--too much of a good thing?
    Lancet; 1990 Dec; 336(8727):1352-3. PubMed ID: 1978168
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study.
    Schneider R; Schneider M; Reiners C; Schneider P
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3926-34. PubMed ID: 22977269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of bone density in women after thyroid cancer surgery and treatment with suppressive doses of L-thyroxine].
    Jurecka-Tuleja B; August R; Kukulska A; Bartnikowa W; Deja R; Czernik E; Handkiewicz-Junak D
    Wiad Lek; 2001; 54 Suppl 1():378-82. PubMed ID: 12182053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
    Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thyroid and osteoporosis].
    Földes J; Lakatos P
    Orv Hetil; 1996 Jun; 137(25):1347-54. PubMed ID: 8757081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
    De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C
    Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
    J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass.
    Jódar E; Begoña López M; García L; Rigopoulou D; Martínez G; Hawkins F
    Osteoporos Int; 1998; 8(4):311-6. PubMed ID: 10024900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses.
    Zelmanovitz F; Genro S; Gross JL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3881-5. PubMed ID: 9814462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levothyroxine therapy and osteoporosis. An end to the controversy?
    Wartofsky L
    Arch Intern Med; 1995 Jun; 155(11):1130-1. PubMed ID: 7763118
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter.
    Wesche MF; Tiel-V Buul MM; Lips P; Smits NJ; Wiersinga WM
    J Clin Endocrinol Metab; 2001 Mar; 86(3):998-1005. PubMed ID: 11238476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone density in differentiated cancer of the thyroid gland treated by hormone-suppressive therapy. Study based on 51 cases].
    Eulry F; Bauduceau B; Lechevalier D; Magnin J; Crozes P; Flageat J; Gautier D
    Rev Rhum Mal Osteoartic; 1992 Apr; 59(4):247-52. PubMed ID: 1496271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.